Healthcare provider profile · identity verified

Floyd Stuart Sanders, MD

Internal Medicine · DEMOREST, GA · NPI 1689763633

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	152
Amlodipine Besylate	Amlodipine Besylate	393	106
Rosuvastatin Calcium	Rosuvastatin Calcium	332	100
Lisinopril	Lisinopril	276	75
Hydrochlorothiazide	Hydrochlorothiazide	249	69
Levothyroxine Sodium	Levothyroxine Sodium	241	62
Metoprolol Succinate	Metoprolol Succinate	207	58
Tamsulosin Hcl	Tamsulosin Hcl	175	50
Metoprolol Tartrate	Metoprolol Tartrate	159	46
Metformin Hcl	Metformin Hcl	157	38
Losartan Potassium	Losartan Potassium	153	43
Gabapentin	Gabapentin	134	35
Omeprazole	Omeprazole	134	40
Montelukast Sodium	Montelukast Sodium	128	31
Tramadol Hcl	Tramadol Hcl	128	30
Meloxicam	Meloxicam	114	35
Trazodone Hcl	Trazodone Hcl	112	30
Citalopram Hbr	Citalopram Hydrobromide	111	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	103	29
Albuterol Sulfate Hfa	Albuterol Sulfate	101	35
Alprazolam	Alprazolam	98	23
Pantoprazole Sodium	Pantoprazole Sodium	94	28
Allopurinol	Allopurinol	90	26
Pravastatin Sodium	Pravastatin Sodium	84	22
Eliquis	Apixaban	79	20
Duloxetine Hcl	Duloxetine Hcl	77	19
Glipizide	Glipizide	77	20
Benazepril Hcl	Benazepril Hcl	75	19
Atenolol	Atenolol	72	21
Finasteride	Finasteride	70	18
Potassium Chloride	Potassium Chloride	69	21
Ezetimibe	Ezetimibe	67	22
Celecoxib	Celecoxib	64	16
Furosemide	Furosemide	61	23
Azithromycin	Azithromycin	59	51
Farxiga	Dapagliflozin Propanediol	55	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	16
Donepezil Hcl	Donepezil Hcl	54	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	suppressed
Xarelto	Rivaroxaban	51	13
Clopidogrel	Clopidogrel Bisulfate	49	15
Januvia	Sitagliptin Phosphate	45	11
Famotidine	Famotidine	44	14
Doxycycline Hyclate	Doxycycline Hyclate	43	33
Sertraline Hcl	Sertraline Hcl	43	12
Mounjaro	Tirzepatide	41	suppressed
Carvedilol	Carvedilol	40	11
Dexamethasone	Dexamethasone	39	33
Jardiance	Empagliflozin	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Metformin Hcl Er	Metformin Hcl	37	suppressed
Clonidine Hcl	Clonidine Hcl	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	11
Flecainide Acetate	Flecainide Acetate	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Amoxicillin	Amoxicillin	26	24
Pregabalin	Pregabalin	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Ondansetron Odt	Ondansetron	25	13
Ozempic	Semaglutide	25	suppressed
Simvastatin	Simvastatin	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	20
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Nitroglycerin	Nitroglycerin	23	17
Methylprednisolone	Methylprednisolone	22	20
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Sucralfate	Sucralfate	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Estradiol	Estradiol	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Indapamide	Indapamide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Prednisone	Prednisone	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Gemtesa	Vibegron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error